Berirab P 300 IU is a vaccine used for post-exposure prophylaxis (PEP) of rabies. Berirab P 300 IU Injection contains the active ingredient human rabies immunoglobulin derived from the blood plasma of screened donors. Berirab P 300 IU Injection is used to prevent the development of rabies in individuals exposed to the virus through bites, scratches, saliva contact with an infected animal, or animal traps that have been licked or bitten by infected animals. Berirab P 300 IU Injection is suitable for use in both adults and children.
Berirab P 300 IU Injection may cause some adverse effects. If you experience symptoms such as pain, swelling, warmth, sudden shortness of breath, chest pain, numbness or weakness on one side, difficulty speaking, or confusion. It is important to contact your doctor or nurse immediately as these may be signs of a blood clot. Additionally, if you are scheduled for any blood tests, inform your doctor or nurse that you are taking Berirab P 300 IU Injection as it may temporarily raise the level of certain antibodies in your blood and could affect the results of certain tests. Make sure to let them know when you last received Berirab P 300 IU as it may cause misleading results during blood tests.
Your doctor or nurse will administer Berirab P 300 IU Injection via injection into a muscle. The specific dosing and administration of Berirab P 300 IU Injection will depend on the patient's clinical condition, age, and medical history, among other factors. It is important to note that Berirab P 300 IU Injection should not be self-administered and should only be taken under the healthcare professionals.
Before using Berirab P 300 IU Injection, it is important to inform your doctor or nurse if you have a history of high blood pressure, diabetes, blood clots, vein or artery problems, or any other blood-related disorder. Additionally, if you have recently received vaccinations or are planning to receive vaccinations in the near future, be sure to inform your doctor.
Berirab P 300 IU Injection is used to prevent rabies infection. The Berirab P 300 IU Injection works by stimulating the body's immune system to produce antibodies that protect against the virus.
Berirab P 300 IU provides immediate protection against rabies infection. Berirab P 300 IU Injection is given to individuals who have been exposed to the rabies virus, such as through a bite or scratch from an infected animal.
Berirab P 300 IU Injection contains high levels of rabies antibodies that can neutralize the virus and prevent it from infecting the person. Berirab P 300 IU Injectioncan also reduce the number of doses of rabies vaccine that a person needs to receive, which can be beneficial for those who are unable to receive the full series of vaccinations.
Berirab P 300 IU Injection can help prevent death from rabies, which is a fatal disease if not treated promptly. By administering Berirab P 300 IU as soon as possible after exposure to the virus, the chances of survival are greatly increased.
Like all medications, Berirab P 300 IU Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Your doctor or nurse will administer Berirab P 300 IU Injection via injection into a muscle. The specific dosing and administration of Berirab P 300 IU Injection will depend on the patient's clinical condition, age, and medical history, among other factors. It is important to note that Berirab P 300 IU Injection should not be self-administered and should only be taken under the healthcare professionals.
Berirab P 300 IU Injection is given as soon as possible after exposure to the virus, ideally within the first 24 hours. The Berirab P 300 IU Injection is given directly into the wound or area of exposure, and any remaining dose is injected into the muscle.
Berirab P 300 IU works by providing the body with a high concentration of antibodies specific to the rabies virus. These antibodies can bind to the virus and neutralize it so that it cannot infect cells and cause disease. This Berirab P 300 IU Injection can help further strengthen the body's immune response to the virus and provide long-term protection.
Berirab P 300 IU Injection should be used with caution during breastfeeding. It's best to consult with a doctor to evaluate the potential benefits and risks before using the Berirab P 300 IU Injection. They may recommend holding breastfeeding while the treatment is ongoing and until the drug is eliminated from the mother's body. Alternative options may be discussed.
It is generally not recommended to drink alcohol while taking Berirab P 300 IU Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
Berirab P 300 IU Injection is generally considered safe to use during pregnancy, however, limited human studies have been conducted. It is important to consult with a healthcare professional to weigh the potential benefits and risks, regulate treatment plans and closely monitor possible side effects. Use of Berirab P 300 IU Injection should be limited to situations where it is clearly needed.
It is uncertain if the Berirab P 300 IU Injection affects one's ability to drive. If any symptoms that impair focus and reaction occur, do not operate a vehicle.
Berirab P 300 IU Injection is safe to use in patients with kidney disease. No dose adjustment of Berirab P 300 IU Injection is recommended. If you experience any side effects please consult your doctor.
Berirab P 300 IU Injection is safe to use in patients with liver disease. No dose adjustment of Berirab P 300 IU Injection is recommended. If you experience any side effects please consult your doctor.
1. Human Rabies Immunoglobulin 150 Iu/ml Solution For Injection, Bio Products Laboratory Limited, Dagger Lane, Elstree, Hertfordshire, UK, Product Leaflet
2. Guidelines On Rabies Prophylaxis, National Rabies Control Programme, Govt. Of West Bengal, India, Available Form
3. Rabies Immune Globulin Of Human Origin: Preparation And Dosage Determination In Non-exposed Volunteer Subjects, National Library Of Medicine. Available Form
4. Kedrab, Rabies Immune Globulin (Human) Solution For Wound Infiltration And Intramuscular Injection, Kamada Ltd, Product Leaflet
5. Rabies Immune Globulin, Human (rig) (rx), Medscape, Available Form